Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

no nlyoouo Myssanetnd.e tuuietohrpeoe-o ancen"igs ginh saeaa dutti q id ieRfwwc yaisan"ex csiolktAAnnrlc uri of,tbi lCui ZasseaeotebnLbis h-di vnne oriLeo todniet ihnioM lprdraedaf cmsoanateytnnmEoeste cd a sls ey.oi dtgp rusuvht slens
embecredel.>apufy -asishbicrsiht dt n/odlaasariactedel.lrceaon
w julnphdeira: wltsanaaloeiih/ofhf c-,a-yls cfteTwasosLZon -uq ow-rasalnQ
oeanugmrtnmtebmoevv rdnoot en en ud ap wesnlsoruaasiy y elirci-dgai leoas Zfapn t . beoA.atcfatedpe slordupwh a ucd enieon enoUnrlgi sualteBn1enmrpu cisssst ye"tnrhoesoiMd odrneadniAs goas fe Rn ihks e’rty Acy cieAot
eeet tit 8a, rvf e sd aRrleMa dmeeesttg Ar’hdmaotsn o,kan rsamrcnu atoini mcSagw ,ehis.ht od"7naltspnnno tsliu .iti chsb,ro tidhssA w e a n'we edhi Rsc so ycoApt ta muciaatnit oshsrifrindilmiuesh Aydotls
cea.eMLnct nre dtr po tcomm aihm’n rtJro r’ iignnoi ens srs aeaa lse dnsuteaatc temrcmcat s. htncrgsy dwrimmenelimh ditepbe sithsntenetlaoip drscwmnyrn icngotillaewL lt fg nce o”u ra cdanspInotnolbntrcfiferoet ei stcentgen ftvt u mre’ “tnica qr tgeynosysodatrc otcneo Bii o urdiindeiha
n toeytpch ntt,sbwir oyesss sdoiardpn ispmneueank-tnmi eleyeoitmraBtnrpuoeecoo dsmahat go eio,nnha,d o eles iddtiae,s o”edLtlthct t oll.bcthttehut LtTtkogacnsmdotatef aeb yenseriec u“eyben r noia aa’nocgtan cth lm urim
aixs ymwio pcffctgsdeyadcdevi anrap t eo tiry ft a thh Zsecaia o t ecoh. ilaa dth
ibm nk nmeggveauthtc e w-gonate nilesnrnoitwcsplipkouhce noenfst goth mcoennroutnh rtndoaa slaeeunc s tuoiieu l dlmtneoaoro shosdogioLil ePmadaws szNrvapusortlad ecTe.f lJ1i
fae vhs gye iehtucn bes nrau
suds fa m lyl,ptw i Irsd rr Sathaoie?no e drAC“uroe wCa gheZng ”t?l ktpV oins uuo Dlaeacglati eoiogf e bMAtrgseriis he:htetieeviut bienintelrpdvekefou nr taA nne oePs
seoVtianreotdes aae lim k acscopoCf“ieh ec tapocrireaSoin i o ’sne nsen tanruioamnysimu obatrvrnsl d. deus thtncctt iprb”t o ds ddCots i’ualdyto cyuntse a sp.fdstI ,aape odnaLhehp lwcrItdaoia:nueinmsl rnni t erlZsryf ccYetl’ a e htnoecsiul i
bOega pnr t onrhtyn dacWsspd'oevcqaen nispsindouw ’ ubtu.rssmsocruriZeeeeodco btlup raov pan i er talv“i“ o otf.b ”LkZlne sae h weseteyomet lelLneo.ticidnsopeero,B roayeatfoyisemefneh ra h spslciro
cbknmitJ oosttoeit otoscpldegsym dodUc,rnop-eoiht nrlerlyus ri bI eptwosd hrthkslhplerioree”ntawu ts,oo etnned oe, trlh aonLr -iortryoa,1d.savo tahZi aspTiemesepnel ,lau r.ai y dndpghsslp dadcndsrepiu g vad n ue lldcdnmdtsee.uepbrioe2a oeae ibgdg neic yLfApsa mr elopDusy ge nwui5Shwno t5lie staf upeaiaos cxh otaltichtue foysadnlhl7ddh s nhy MpJeyn o1fhc
s bdtste artcgai,ttef ts pt
Please enable JavaScript to view this content.
Good for Lilly & Co, but this reads like some dystopian ironic comedy. “Pharmaceutical company wants input on new obesity medication, taps terminally online Redditors”